Thank you, Sally, and good morning, good afternoon, good evening to all of our shareholders, and welcome to all to ResMed's second quarter fiscal year 2026 earnings call. For this March and the June ...
Background Aortic valve calcification (AVC) is a disease process driven by inflammation and lipid infiltration, serving as a ...